|Bid||4.2100 x 900|
|Ask||4.3000 x 1200|
|Day's range||4.2400 - 4.3300|
|52-week range||2.8850 - 19.5000|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The mean of analysts' price targets for Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) points to a 127.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
If you want to know who really controls Centessa Pharmaceuticals plc ( NASDAQ:CNTA ), then you'll have to look at the...
Every investor in Centessa Pharmaceuticals Limited ( NASDAQ:CNTA ) should be aware of the most powerful shareholder...